Clinical Trials
26 trialsNCT03581773 2026-05-04
DARENCA4
University of Aarhus
Phase 2 Recruiting
NCT05635929 2026-04-15
STOPOMP
Mucosa Innovations, S.L.
Phase NA Recruiting
NCT06623305 2025-10-24
PBM
Medical College of Wisconsin
Phase NA Not yet recruiting
NCT04382079 2025-03-05
Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial
Taipei Medical University
Phase NA Completed
NCT05966194 2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2 Recruiting
NCT03515538 2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2 Completed
NCT04440930 2023-09-05
White Tea for Prevention of Chemotherapy Induced Mucositis
Vejle Hospital
Phase NA Completed
NCT04648020 2023-05-31
VOICE
Monopar Therapeutics
Phase 2/3 Terminated
NCT04843644 2021-04-13
Microbiota and Symptom Distress in Head and Neck Cancer Patients Receiving Radiotherapy
Taipei Medical University
Phase NA Unknown
NCT01092975 2020-12-28
Safety of Phenylephrine for Oral Mucositis Prevention
University of Wisconsin, Madison
Phase 1 Terminated
NCT02606994 2019-02-06
TPvsM
Oral Defense, LLC
Phase 2 Terminated
NCT02324335 2019-01-16
Brilacidin
Innovation Pharmaceuticals, Inc.
Phase 2 Completed
NCT02885376 2018-12-21
Study of Dentoxol® Mouthrinse for Oral Mucositis
Ingalfarma SpA
Phase 2 Completed
NCT02630004 2018-03-01
MUCOMEL
Spherium Biomed
Phase 1/2 Completed
NCT01898091 2017-03-06
OM
Medical University of South Carolina
Phase 2 Completed
NCT00101582 2016-09-27
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
Swedish Orphan Biovitrum
Phase 3 Completed
NCT02282839 2015-11-04
Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation
Taichung Veterans General Hospital
Phase 3 Unknown
NCT00698204 2014-06-05
Cox-2 Inhibition in Radiation-induced Oral Mucositis
UConn Health
Phase 2 Completed
NCT01247246 2014-05-26
Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer
SciClone Pharmaceuticals
Phase 2 Unknown
NCT01283906 2013-09-12
MuGard
Access Pharmaceuticals, Inc.
Phase 4 Completed
NCT01837446 2013-04-23
Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer
Isfahan University of Medical Sciences
Phase 2/3 Completed
NCT00965172 2012-03-22
Caphosol in Sarcoma Patients With Mucositis
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01007617 2011-01-19
Low-energy Laser Therapy for Prevention of Oral Mucositis in Children
University Hospital, Clermont-Ferrand
Phase 2/3 Unknown
NCT00584597 2010-12-13
TRAUMEEL
University of Oklahoma
Phase 1 Completed
NCT01083875 2010-03-18
Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region
Access Pharmaceuticals, Inc.
Phase 2 Completed
NCT00230191 2007-01-15
Safety and Efficacy of RK0202 in Oral Mucositis
RxKinetix
Phase 2 Completed